跳至主要内容
临床试验/JPRN-UMIN000005455
JPRN-UMIN000005455已完成3 期

Adjuvant InterFeron After Curative Resection of HCV-related Hepatocellular Carcinoma in Elderly Patients: a Multicenter Randomized Controlled Trial - iFACT trial

Tokyo University Hospital0 个研究点目标入组 300 人开始时间: 2011年4月20日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
发起方
入组人数
300

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
61years-old 至 77years-old(—)
性别
All

入选标准

  • 未提供

排除标准

  • 1)Positive HBs-Ag 2)Other anticancer treatment or interferon therapy within 3 months before surgery. 3)Specific drug which is forbidden in this trial is needed. 4)Participating in other clinical trial regarding HCC 5)Autoimmune hepatitis, alcoholic hepatitis, etc. 6)Allergy for specific biologics 7)Severe postoperative complications 8)Asthma 9)Diabetes requiring insulin therapy 10)Severe hypertension 11)Heart disease that complicates perioperative treatments 12)Interstitial pneumonia 13)Psychiatric disorder 14)Malignant disease in other organ within 5 years 15)Moderate or severe renal dysfunction (estimated Ccr < 30ml/min) 16)Other reason that an attending doctor considers

研究者

发起方
Tokyo University Hospital

相似试验